The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections.

Delivery efficiencies of theranostic nanoparticles (NPs) based on passive tumor targeting strongly depend either on their blood circulation time or on appropriate modulations of the tumor ...